ArticleJAMA network open2023

Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma: A Nonrandomized Controlled Trial.

Nancy Y Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.